ISRCTN10756993进行中(未招募)未知
Preventing physical and psychological symptoms among cancer survivors through a mindfulness psychoeducation programme: a randomised controlled trial
ational University of Singapore0 个研究点目标入组 210 人开始时间: 2022年4月29日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 进行中(未招募)
- 发起方
- 入组人数
- 210
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •Current inclusion criteria as of 29/08/2024:
- •1. Adults of any gender aged 21 to 75 years
- •2. Having a confirmed diagnosis of any type of cancer stage 0 to III by their attending physician
- •3. Have completed all cancer and related treatments (such as chemotherapy, surgery, and radiotherapy, as prescribed by their attending physician), with the exception of hormonal therapy between 2 weeks to 2 years (Lengacher et al., 2016)
- •Previous inclusion criteria:
- •1. Adults of any gender aged 21 to 65 years
- •2. Having a confirmed diagnosis of any type of cancer stage 0 to III by their attending physician
- •3. Have completed all cancer and related treatments (such as chemotherapy, surgery, and radiotherapy, as prescribed by their attending physician), with the exception of hormonal therapy between 2 weeks to 2 years (Lengacher et al., 2016)
排除标准
- •1. Having a diagnosis of severe mental disorders (e.g., schizophrenia, mood disorders, bipolar disorder, and substance-related disorders)
- •2. Having a severe medical condition requiring hospitalisation
- •3. Is pregnant
研究者
相似试验
已完成
不适用
Prevention of depressive symptoms, anxiety, distress and irrational thoughts among victims of cyberbullying on the Vmbo through an online tailored advice.NL-OMON39069Open Universiteit3,570
已完成
2 期
Prevention of the progression of very early symptoms into ankylosing spondylitisankylosing spondylitis10023213spondyloarthritisNL-OMON36697Vrije Universiteit Medisch Centrum80
已完成
不适用
Preventive Methods for Reduction of Pain associated with Propofol Injection: a randomised controlled trial of commonly used methodsPain Injection10001316NL-OMON36046Catharina-ziekenhuis436
进行中(未招募)
1 期
Hydrocortisone as co-treatment to prevent neuropsychiatric adverse effects of dexamethasone.europsychiatric adverse effects which can be caused by dexamethasone. For example delirium, anxiety, depression, mania and psychosis. But also cognitive impairment and sleep disturbance.EUCTR2017-003705-17-NLMC180
招募中
4 期
Prevention of neuropsychiatric adverse effects caused by dexamethasone: insights from a placebo-controlled trial with hydrocortisone.NL-OMON54782eids Universitair Medisch Centrum180
